ClinicalTrials.govpublic full text
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
plasma cell myeloma refractory, anti cd38 monoclonal antibody, sarclisa, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 994934
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.